$RIBT Price/sales looks like a bargain to me
https://www.investopedia.com/terms/p/price-to-salesratio.asp
Yahoo shows it 7.08, but Yahoo is yet factoring in the sales we get from Golden Ridge. If I take Rystrom's low 2019 forecast of $40,000,000 and figure in 32,000,000 shares by then, 1.25 X today's price of $3.22 and P/S will be an years end--- 2.57.
OK, it varies by industry and potential. Below are some price/sales examples.
ADM - .38-- low margin industry
GIS- - 1.60 bigger margins in manufacturing food products
AMZN - 3.53 - 20% revenue growth this coming quarter
FUSZ - 2,975- Interactive video technology(gaming), developmental company, big sales expected
GLMD- 67.05 Pharma, new products coming
The above is just a small sampling. I base RIBT's P/S at the end of 2019, the others current. Yes the others can change during the year so not an exact comparison. BTW, I don't think Rystrom told us what Golden Ridge was going to do sales wise in 2018. That makes it hard to see the affect RIBT will have there, would be nice to know.
My point, RIBT's year end P/S at 2.57 Looks really low compared to AMZN to me. RIBT with it's rice bran protein has a much easier chance of doubling revenue in 2020 than AMZN, IMO. I feel RIBT is a cross between GLMD and AMZN. If RIBT's price/sales was 3 times higher than now, I'd call it fair. So, that is a $9.66 stock, with what we know now. Get some speculators in and even higher.
The problem is the street does not even know about Golden Ridge, when they look at the Yahoo statistics. They don't know about rice bran potential and the potential, especially the SRB protein is like a pharma product to me, maybe not a blockbuster pharma product, but a good one.
When the Year End CC happens in mid March, any good news and RIBT is a $5.00+ stock. One potential positive unknown is why Rystrom wants the $4,000,000 from the $3.25 warrants that expire in mid April. hmmmmm.
Of course, any good news before the CC gives us a $5.00 stock, IMO.
https://stockcharts.com/h-sc/ui?s=RIBT&p=...731353837c
Thoughts or comments?
https://www.investopedia.com/terms/p/price-to-salesratio.asp
Yahoo shows it 7.08, but Yahoo is yet factoring in the sales we get from Golden Ridge. If I take Rystrom's low 2019 forecast of $40,000,000 and figure in 32,000,000 shares by then, 1.25 X today's price of $3.22 and P/S will be an years end--- 2.57.
OK, it varies by industry and potential. Below are some price/sales examples.
ADM - .38-- low margin industry
GIS- - 1.60 bigger margins in manufacturing food products
AMZN - 3.53 - 20% revenue growth this coming quarter
FUSZ - 2,975- Interactive video technology(gaming), developmental company, big sales expected
GLMD- 67.05 Pharma, new products coming
The above is just a small sampling. I base RIBT's P/S at the end of 2019, the others current. Yes the others can change during the year so not an exact comparison. BTW, I don't think Rystrom told us what Golden Ridge was going to do sales wise in 2018. That makes it hard to see the affect RIBT will have there, would be nice to know.
My point, RIBT's year end P/S at 2.57 Looks really low compared to AMZN to me. RIBT with it's rice bran protein has a much easier chance of doubling revenue in 2020 than AMZN, IMO. I feel RIBT is a cross between GLMD and AMZN. If RIBT's price/sales was 3 times higher than now, I'd call it fair. So, that is a $9.66 stock, with what we know now. Get some speculators in and even higher.
The problem is the street does not even know about Golden Ridge, when they look at the Yahoo statistics. They don't know about rice bran potential and the potential, especially the SRB protein is like a pharma product to me, maybe not a blockbuster pharma product, but a good one.
When the Year End CC happens in mid March, any good news and RIBT is a $5.00+ stock. One potential positive unknown is why Rystrom wants the $4,000,000 from the $3.25 warrants that expire in mid April. hmmmmm.
Of course, any good news before the CC gives us a $5.00 stock, IMO.
https://stockcharts.com/h-sc/ui?s=RIBT&p=...731353837c
Thoughts or comments?
